학술논문
HR+HER2- breast cancers with growth factor receptor--mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
Document Type
Article
Author
Source
Tumor Biology (IOS Press); Mar2017, Vol. 39 Issue 3, p1-13, 13p, 2 Charts, 3 Graphs
Subject
Language
ISSN
10104283
Abstract
Copyright of Tumor Biology (IOS Press) is the property of IOS Press and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)